“…These included duration of TDF exposure, history of TDF use, current TDF use, time from the diagnosis of HIV-1 infection, duration of ART, current ART regimen, age, sex, height, body weight, body mass index (BMI; body weight [kg]/height [m] 2 ), history of AIDS (defined as history of or concurrent presence of one of the 23 AIDS-defining diseases including opportunistic infections and malignancies set by the Japanese Ministry of Health, Labour and Welfare) 22 , HIV-1 transmission route, laboratory data (CD4 cell count, HIV viral load, and serum creatinine level, urine dipstick test), and presence or absence of other medical conditions (concurrent nephrotoxic drugs, such as ganciclovir, NSAIDs, and sulfamethoxazole/trimethoprim; diabetes mellitus defined as the use of glucose-lowering agents; hypertension defined as current treatment with antihypertensive agents; dyslipidemia defined as current treatment with lipid-lowering agents; hepatitis B infection defined as positive hepatitis B surface antigen; hepatitis C infection defined as positive HCV antibody; and smoking (if one ever smoked or not). Patients visited our clinic at least every 3 months for measurement of CD4 cell count, HIV-1 viral load, and eGFR, since the prescription period under the Japanese health care system is limited to 3 months 23 . The data of the latest day during the study period when both serum creatinine and CD4 counts were measured were used.…”